Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Processa Pharmaceuticals, Inc. | 300,000 | reported | 01 Oct 2025 | tx 9+771,280−14,407 |
| XOMA Royalty Corp | 11,822 | reported | 15 Jul 2022 | tx 108+1,333,272−522,703.4 |
| Akari Therapeutics Plc | 3,093 | reported | 16 Dec 2025 | tx 11+10,424,524 |
| Ignyte Acquisition Corp. | 0 | reported | 14 Nov 2024 | tx 7+71,190−571,190 |
| PALISADE BIO, INC. | 0 | reported | 09 Feb 2024 | tx 19+124,661−29,960 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 3,093 | — | derivfirst after silence |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 3,093 | 0.40 USD | deriv |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 2,473 | — | deriv |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 2,473 | 0.40 USD | deriv |
| 01 Oct 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 100,000 | 0.00 USD | deriv |
| 01 Oct 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 300,000 | 0.00 USD | deriv |
| 24 Jul 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 175,299 | 0.00 USD | deriv |
| 20 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 175,000 | 0.00 USD | deriv |
| 20 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 225,000 | 0.00 USD | deriv |
| 06 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 4,464 | 1.12 USD | |
| 06 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 4,464 | 1.12 USD | deriv |
| 06 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 4,464 | 1.12 USD | deriv |
| 09 Jan 2025 | GRANT_AWARD | Akari Therapeutics Plc | 8,000,000 | 0.00 USD | |
| 23 Dec 2024 | GRANT_AWARD | Akari Therapeutics Plc | 2,000,000 | 0.00 USD | |
| 14 Nov 2024 | CONVERSION | Ignyte Acquisition Corp. | 37,850 | — | |
| 14 Nov 2024 | OTHER | Ignyte Acquisition Corp. | 37,850 | — | |
| 14 Nov 2024 | OTHER | Ignyte Acquisition Corp. | — | 0.00 USD | deriv |
| 14 Nov 2024 | CONVERSION | Ignyte Acquisition Corp. | 33,340 | — | deriv |
| 14 Nov 2024 | OTHER | Ignyte Acquisition Corp. | 500,000 | — | deriv |
| 03 Sept 2024 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 31,206 | 0.00 USD | deriv |
| 09 Feb 2024 | EXERCISE | PALISADE BIO, INC. | 5,820 | 0.00 USD | |
| 09 Feb 2024 | EXERCISE | PALISADE BIO, INC. | 5,100 | 0.00 USD | |
| 09 Feb 2024 | EXERCISE | PALISADE BIO, INC. | 6,880 | 0.00 USD | deriv |
| 09 Feb 2024 | EXERCISE | PALISADE BIO, INC. | 5,100 | 0.00 USD | deriv |
| 09 Feb 2024 | EXERCISE | PALISADE BIO, INC. | 5,820 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 16 Dec 2025.